OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Allergy and Clinical Immunology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
What molecular allergy teaches us about genetics and epidemiology of allergies	52
The use of environmental exposure chambers in studies related to ocular surface effects	34
Consequences of severe asthma exacerbations	31
The pathogenetic role of Th17 immune response in atopic dermatitis	31
Economic burden of drug-induced anaphylaxis: what can we do better?	26
Is immunotherapy safe for treatment of severe asthma	25
Chronic spontaneous urticaria: new evidences on the role of autoimmunity	22
Liver disease in primary antibody deficiencies	22
Anaphylaxis due to antiallergic and antiasthmatic biologics	21
E-cigarettes and asthma in adolescents	18
Drug allergy awareness and perspectives with the implementation of the International Classification of Diseases-11	17
The collaborative medical practice of the ocular surface: a major role of the allergist/immunologist	16
Dietary strategies for the prevention of asthma in children	16
Real-world evidence of allergen immunotherapy	15
Cow's milk allergy	15
Pulmonary function testing for the diagnosis of asthma in preschool children	15
Editorial: Food allergy: from defense to attack	14
New approaches in childhood asthma treatment	14
Atopic manifestations of inborn errors of immunity	14
Innate and adaptive immunity in allergic airway disease	13
Transition of care in inborn errors of immunity	12
Editorial introductions	12
Neuroimmune signalling pathways in chronic rhinosinusitis with nasal polyps	12
Vernal keratoconjunctivitis and keratoconus	12
Biologics as treatment options for anaphylaxis	12

Bronchiectasis and obstructive lung diseases in primary antibody deficiencies and beyond: update on management and pathomechanisms	12
Update on occupational allergy, including asthma, to soluble platinum salts	12
Autologous serum eye drops for ocular surface disorders	12
The effects of the COVID-19 pandemic on the treatment of allergic eye diseases	12
Mast cell conditions and drug allergy: when to suspect and how to manage	12
Ocular involvement in allergic drug reactions	11
Editorial introductions	11
Paucity of gastrointestinal plasma cells in common variable immunodeficiency	11
Epidemiology of the relationship between allergic bronchopulmonary aspergillosis and asthma	10
Biological therapies, asthma and coronavirus disease 2019	10
Perioperative anaphylaxis: when the allergological work-up goes negative	10
Is allergen immunotherapy a model of personalized treatment in pediatric respiratory allergy?	10
Editorial introductions	10
Drug allergy desensitization is not a unique recipe	10
Nanoparticles in allergen immunotherapy	10
Updates in diagnosis and management of paediatric mastocytosis	9
A review of food allergy-related costs with consideration to clinical and demographic factors	9
Updates in school-based asthma management	9
LNIT-Local nasal immunotherapy in allergic rhinitis: revisited evidence and perspectives	9
Evaluating the glucagon-like peptide-1 receptor in managing asthma	9
Clinical remission in severe asthma: lights and shadows on an ambitious goal	9
Editorial introductions	9
Editorial introductions	9
Management and treatment of perioperative hypersensitivity	9
An immunologist's perspective on anti-COVID-19 vaccines	9
Basophil activation test in food allergy: is it ready for real-time?	8
Food-labeling issues for severe food-allergic consumers	8
Editorial: Advances in drug hypersensitivity reactions	8
Chronic rhinosinusitis with nasal polyps: eosinophils versus B lymphocytes in disease pathogenesis	8
Occupational causes of chronic obstructive pulmonary disease: an update	8
Health disparities in allergic diseases	8
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review	8
Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches	7
The complexity in DNA methylation analysis of allergic diseases	7
Biomarkers in the diagnosis of mast cell activation	7
Role of the ocular surface microbiome in allergic eye diseases	7
What's new in pediatric asthma and rhinitis phenotypes and endotypes?	7
Editorial introductions	7
Food allergy: new therapeutic options open deeper questions	7
Strengthening the case for intralymphatic immunotherapy	7
Update on hereditary C1q deficiency: pathophysiology, clinical presentation, genotype and management	7
Atopic dermatitis endotypes: knowledge for personalized medicine	7
Precision allergy molecular diagnosis applications in food allergy	6
Immunobiologicals and ocular surface disease	6
The role of macrolides in chronic rhinosinusitis and nasal polyps	6
Interstitial lung diseases in inborn errors of immunity	6
Adverse effects of anti-cancer biologics on the ocular surface	6
Current strategies for phenotyping and managing asthma in preschool children	6
Anaphylaxis and Coronavirus Disease 2019 vaccine: a danger relationship?	6
Precision medicine to personalize medicine in allergic airway disease	6

Access from healthcare professionals to evidence-based pharmacotherapy in allergy management	6
Neurotrophic keratitis: inflammatory pathogenesis and novel therapies	6
Pathology of T-cell-mediated drug hypersensitivity reactions and impact of tolerance mechanisms on patient susceptibility	6
Do bacterial vaccines/adjuvants prevent wheezing episodes in children?	6
Exposome mapping in chronic respiratory diseases: the added value of digital technology	6
Atopic dermatitis and ocular allergy: common mechanisms and uncommon questions	6
Occupational respiratory allergy to reactive dyes	6
Poor statistical reporting: do we have a reason for concern? A narrative review and recommendations	6